Escalon Medical Corp. (ESMC)
USD 0.2
(0.0%)
USD 0.2
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 315.68 Thousand USD | 153893.17% |
| 2023 | 205.00 USD | -99.97% |
| 2022 | 611.17 Thousand USD | 404.16% |
| 2021 | 121.22 Thousand USD | -90.03% |
| 2020 | 1.21 Million USD | 740.27% |
| 2019 | -189.87 Thousand USD | 72.39% |
| 2018 | -687.81 Thousand USD | -374.16% |
| 2017 | 250.88 Thousand USD | 195.35% |
| 2016 | -263.11 Thousand USD | 82.65% |
| 2015 | -1.51 Million USD | 24.52% |
| 2014 | -2 Million USD | 24.3% |
| 2013 | -2.65 Million USD | -181.46% |
| 2012 | 3.25 Million USD | 13.59% |
| 2011 | 2.86 Million USD | 246.38% |
| 2010 | 828.31 Thousand USD | -80.76% |
| 2009 | 4.3 Million USD | 245.67% |
| 2008 | -2.95 Million USD | -2067.93% |
| 2007 | 150.2 Thousand USD | 105.03% |
| 2006 | -2.98 Million USD | 33.59% |
| 2005 | -4.49 Million USD | 46.08% |
| 2004 | -8.33 Million USD | -232.98% |
| 2003 | 6.26 Million USD | -24.55% |
| 2002 | 8.3 Million USD | -21.47% |
| 2001 | 10.57 Million USD | 4.16% |
| 2000 | 10.15 Million USD | 607.75% |
| 1999 | -2 Million USD | 13.04% |
| 1998 | -2.3 Million USD | -27.78% |
| 1997 | -1.8 Million USD | 30.77% |
| 1996 | -2.6 Million USD | 25.71% |
| 1995 | -3.5 Million USD | -20.69% |
| 1994 | -2.9 Million USD | -3000.0% |
| 1993 | 100 Thousand USD | -85.71% |
| 1992 | 700 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -280.65 Thousand USD | -137003.9% |
| 2024 Q3 | -206.96 Thousand USD | -440.03% |
| 2024 Q4 | 315.68 Thousand USD | 252.53% |
| 2024 Q2 | 60.86 Thousand USD | 121.69% |
| 2023 Q1 | 855.29 Thousand USD | 39.94% |
| 2023 Q4 | 205.00 USD | -99.95% |
| 2023 FY | 205.00 USD | -99.97% |
| 2023 Q3 | 428.46 Thousand USD | -42.08% |
| 2023 Q2 | 739.81 Thousand USD | -13.5% |
| 2022 Q4 | 611.17 Thousand USD | 8403.84% |
| 2022 FY | 611.17 Thousand USD | 404.16% |
| 2022 Q1 | -49.96 Thousand USD | -141.22% |
| 2022 Q2 | 65.54 Thousand USD | 231.17% |
| 2022 Q3 | 7187.00 USD | -89.04% |
| 2021 Q3 | 189.26 Thousand USD | -49.93% |
| 2021 Q2 | 378.01 Thousand USD | -38.02% |
| 2021 FY | 121.22 Thousand USD | -90.03% |
| 2021 Q1 | 609.89 Thousand USD | -49.83% |
| 2021 Q4 | 121.22 Thousand USD | -35.95% |
| 2020 Q2 | 1.02 Million USD | 10.17% |
| 2020 Q4 | 1.21 Million USD | 58.05% |
| 2020 FY | 1.21 Million USD | 740.27% |
| 2020 Q1 | 928.78 Thousand USD | 589.17% |
| 2020 Q3 | 769.17 Thousand USD | -24.83% |
| 2019 Q4 | -189.87 Thousand USD | 38.27% |
| 2019 FY | -189.87 Thousand USD | 72.39% |
| 2019 Q3 | -307.6 Thousand USD | 28.64% |
| 2019 Q2 | -431.04 Thousand USD | 37.74% |
| 2019 Q1 | -692.35 Thousand USD | -0.66% |
| 2018 FY | -687.81 Thousand USD | -374.16% |
| 2018 Q1 | 440.11 Thousand USD | 75.43% |
| 2018 Q2 | 46.78 Thousand USD | -89.37% |
| 2018 Q3 | -940.97 Thousand USD | -2111.1% |
| 2018 Q4 | -687.81 Thousand USD | 26.9% |
| 2017 Q4 | 250.88 Thousand USD | -32.02% |
| 2017 FY | 250.88 Thousand USD | 195.35% |
| 2017 Q1 | -97.53 Thousand USD | 62.93% |
| 2017 Q2 | 253.71 Thousand USD | 360.13% |
| 2017 Q3 | 369.05 Thousand USD | 45.46% |
| 2016 Q3 | -468.58 Thousand USD | -100.03% |
| 2016 Q1 | 1.28 Billion USD | -15.81% |
| 2016 Q2 | 1.4 Billion USD | 9.15% |
| 2016 Q4 | -263.11 Thousand USD | 43.85% |
| 2016 FY | -263.11 Thousand USD | 82.65% |
| 2015 Q3 | 1.32 Billion USD | 16.64% |
| 2015 Q1 | 1.01 Billion USD | -12.71% |
| 2015 Q4 | 1.52 Billion USD | 15.5% |
| 2015 FY | -1.51 Million USD | 24.52% |
| 2015 Q2 | 1.13 Billion USD | 11.25% |
| 2014 Q4 | 1.16 Billion USD | 3.38% |
| 2014 Q1 | 907.92 Million USD | -22.31% |
| 2014 Q3 | 1.12 Billion USD | 7.97% |
| 2014 Q2 | 1.04 Billion USD | 15.24% |
| 2014 FY | -2 Million USD | 24.3% |
| 2013 FY | -2.65 Million USD | -181.46% |
| 2013 Q4 | 1.16 Billion USD | 55.32% |
| 2013 Q3 | 752.41 Million USD | -17.72% |
| 2013 Q2 | 914.46 Million USD | 25307.75% |
| 2013 Q1 | 3.59 Million USD | 10.44% |
| 2012 Q4 | 3.25 Million USD | -9.14% |
| 2012 FY | 3.25 Million USD | 13.59% |
| 2012 Q1 | 2.55 Million USD | -10.88% |
| 2012 Q2 | 3.34 Million USD | 30.95% |
| 2012 Q3 | 3.58 Million USD | 7.11% |
| 2011 FY | 2.86 Million USD | 246.38% |
| 2011 Q4 | 2.86 Million USD | 19.82% |
| 2011 Q3 | 2.39 Million USD | 7.9% |
| 2011 Q2 | 2.21 Million USD | 15.76% |
| 2011 Q1 | 1.91 Million USD | 131.44% |
| 2010 FY | 828.31 Thousand USD | -80.76% |
| 2010 Q2 | 5.19 Million USD | 16.56% |
| 2010 Q1 | 4.46 Million USD | 3.6% |
| 2010 Q3 | 4.77 Million USD | -8.23% |
| 2010 Q4 | 828.31 Thousand USD | -82.64% |
| 2009 FY | 4.3 Million USD | 245.67% |
| 2009 Q4 | 4.3 Million USD | -7.75% |
| 2009 Q3 | 4.66 Million USD | 10.54% |
| 2009 Q2 | 4.22 Million USD | 350.86% |
| 2009 Q1 | -1.68 Million USD | 43.05% |
| 2008 Q2 | -7.47 Million USD | 0.81% |
| 2008 Q3 | -6.89 Million USD | 7.78% |
| 2008 Q4 | -2.95 Million USD | 57.1% |
| 2008 FY | -2.95 Million USD | -2067.93% |
| 2008 Q1 | -7.53 Million USD | -5115.66% |
| 2007 Q2 | -1.28 Million USD | 29.29% |
| 2007 Q1 | -1.81 Million USD | 39.24% |
| 2007 FY | 150.2 Thousand USD | 105.03% |
| 2007 Q4 | 150.2 Thousand USD | 101.61% |
| 2007 Q3 | -9.33 Million USD | -628.05% |
| 2006 Q4 | -2.98 Million USD | -11.12% |
| 2006 FY | -2.98 Million USD | 33.59% |
| 2006 Q3 | -2.68 Million USD | 33.99% |
| 2006 Q2 | -4.06 Million USD | 14.58% |
| 2006 Q1 | -4.76 Million USD | -6.0% |
| 2005 Q1 | -3.85 Million USD | 53.69% |
| 2005 Q2 | -2.94 Million USD | 23.6% |
| 2005 FY | -4.49 Million USD | 46.08% |
| 2005 Q3 | -1.82 Million USD | 38.09% |
| 2005 Q4 | -4.49 Million USD | -146.18% |
| 2004 Q3 | -8.24 Million USD | -277.1% |
| 2004 Q4 | -8.33 Million USD | -1.1% |
| 2004 FY | -8.33 Million USD | -232.98% |
| 2004 Q2 | 4.65 Million USD | -17.57% |
| 2004 Q1 | 5.64 Million USD | -9.9% |
| 2003 Q2 | 7.48 Million USD | -6.77% |
| 2003 Q4 | 6.26 Million USD | -12.84% |
| 2003 FY | 6.26 Million USD | -24.55% |
| 2003 Q3 | 7.19 Million USD | -3.9% |
| 2003 Q1 | 8.02 Million USD | -3.38% |
| 2002 Q1 | 9.78 Million USD | -7.46% |
| 2002 Q4 | 8.3 Million USD | -8.55% |
| 2002 FY | 8.3 Million USD | -21.47% |
| 2002 Q3 | 9.08 Million USD | -2.67% |
| 2002 Q2 | 9.33 Million USD | -4.65% |
| 2001 Q3 | 10.97 Million USD | 9.69% |
| 2001 Q1 | 10.22 Million USD | 0.66% |
| 2001 Q2 | 10 Million USD | -2.09% |
| 2001 Q4 | 10.57 Million USD | -3.65% |
| 2001 FY | 10.57 Million USD | 4.16% |
| 2000 Q3 | 10.23 Million USD | 952.77% |
| 2000 Q1 | -2.5 Million USD | -25.0% |
| 2000 FY | 10.15 Million USD | 607.75% |
| 2000 Q4 | 10.15 Million USD | -0.76% |
| 2000 Q2 | -1.2 Million USD | 52.0% |
| 1999 Q3 | -1.6 Million USD | 33.33% |
| 1999 Q4 | -2 Million USD | -25.0% |
| 1999 Q2 | -2.4 Million USD | -9.09% |
| 1999 Q1 | -2.2 Million USD | 4.35% |
| 1999 FY | -2 Million USD | 13.04% |
| 1998 Q4 | -2.3 Million USD | -4.55% |
| 1998 FY | -2.3 Million USD | -27.78% |
| 1998 Q1 | -1.7 Million USD | 5.56% |
| 1998 Q2 | -1.5 Million USD | 11.76% |
| 1998 Q3 | -2.2 Million USD | -46.67% |
| 1997 Q2 | -2.1 Million USD | 4.55% |
| 1997 FY | -1.8 Million USD | 30.77% |
| 1997 Q1 | -2.2 Million USD | 15.38% |
| 1997 Q4 | -1.8 Million USD | 10.0% |
| 1997 Q3 | -2 Million USD | 4.76% |
| 1996 Q2 | -5.5 Million USD | -14.58% |
| 1996 Q4 | -2.6 Million USD | 36.59% |
| 1996 Q3 | -4.1 Million USD | 25.45% |
| 1996 FY | -2.6 Million USD | 25.71% |
| 1996 Q1 | -4.8 Million USD | -37.14% |
| 1995 Q3 | -3 Million USD | -66.67% |
| 1995 FY | -3.5 Million USD | -20.69% |
| 1995 Q4 | -3.5 Million USD | -16.67% |
| 1995 Q2 | -1.8 Million USD | -12.5% |
| 1995 Q1 | -1.6 Million USD | 44.83% |
| 1994 Q2 | -13.3 Million USD | -3225.0% |
| 1994 Q3 | -5.3 Million USD | 60.15% |
| 1994 Q4 | -2.9 Million USD | 45.28% |
| 1994 FY | -2.9 Million USD | -3000.0% |
| 1994 Q1 | -400 Thousand USD | -500.0% |
| 1993 Q4 | 100 Thousand USD | 114.29% |
| 1993 FY | 100 Thousand USD | -85.71% |
| 1993 Q1 | -3.5 Million USD | 0.0% |
| 1993 Q2 | -2.2 Million USD | 37.14% |
| 1993 Q3 | -700 Thousand USD | 68.18% |
| 1992 FY | 700 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 97.871% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -45.741% |
| Polarean Imaging plc | -5.94 Million USD | 105.309% |
| Avitar, Inc. | 5.17 Million USD | 93.895% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -606 Thousand USD | 152.093% |
| AVITA Medical, Inc. | -26.23 Million USD | 101.203% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 4609.8% |
| Össur hf. | 395.08 Million USD | 99.92% |
| Zecotek Photonics Inc. | 2.76 Million USD | 88.572% |
| QHSLab, Inc. | 1.72 Million USD | 81.752% |
| Wellstar International, Inc. | 51.36 Million USD | 99.385% |
| Össur hf. | 395.08 Million USD | 99.92% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 106.837% |
| Aurora Spine Corporation | 1.9 Million USD | 83.452% |
| BrainsWay Ltd. | -10.32 Million USD | 103.059% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 86.928% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 98.258% |
| Vivos Inc. | -1.59 Million USD | 119.826% |
| MicroPort Scientific Corporation | 673.58 Million USD | 99.953% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 35.222% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 158.354% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 50.689% |
| Nanomix Corporation | 11.38 Million USD | 97.228% |
| Theraclion SA | -5.86 Million EUR | 105.383% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 92.079% |
| Positron Corporation | 1.68 Million USD | 81.286% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 80.402% |
| Lombard Medical, Inc. | 11.49 Million USD | 97.254% |
| ALR Technologies Inc. | 19.14 Million USD | 98.351% |
| Stratec SE | 119.12 Million USD | 99.735% |
| Vycor Medical, Inc. | 1.05 Million USD | 70.019% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -474.027% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -238.741% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 102.29% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 98.953% |
| VMS Rehab Systems, Inc. | 133.52 USD | -236333.493% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 78.481% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 49.964% |
| Odyssey Group International, Inc. | 2.1 Million USD | 85.023% |
| United American Healthcare Corporation | -9.32 Million USD | 103.385% |
| ECGI Holdings, Inc. | 3.17 Million USD | 90.045% |
| Capital Group Holdings, Inc. | -3508.00 USD | 9099.031% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -20.207% |
| Urologix, Inc. | 4.61 Million USD | 93.16% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 92.5% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 90.523% |
| SS Innovations International, Inc. | 1.18 Million USD | 73.368% |
| Qualis Innovations, Inc. | 6671.00 USD | -4632.214% |
| Smith & Nephew plc | 2.77 Billion USD | 99.989% |
| NIOX Group Plc | -23.93 Million USD | 101.319% |
| Fuse Medical, Inc. | 1.75 Million USD | 82.017% |
| Broncus Holding Corporation | -81.42 Million USD | 100.388% |
| Brain Scientific Inc. | 2.11 Million USD | 85.079% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 98.608% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -698.053% |